Articles Found

Page: « Previous 1 2 3 4 5 6 7 8 9 10 ... Next »

Recent Articles  Industry   Published  Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con Pharma / BioTech / Nutrition 2026/05/28 More Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity Pharma / BioTech / Nutrition 2026/05/20 More Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium Pharma / BioTech / Nutrition 2026/05/14 More SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure Pharma / BioTech / Nutrition 2026/04/28 More Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma Pharma / BioTech / Nutrition 2026/04/22 More Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan Pharma / BioTech / Nutrition 2026/03/26 More Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition Pharma / BioTech / Nutrition 2026/03/25 More Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR Pharma / BioTech / Nutrition 2026/03/18 More Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology Pharma / BioTech / Nutrition 2026/03/03 More Ono Pharma Announces Transfer of the Manufacturing and Marketing Approval Authorization for Opalmon® Tablets and Prostandin® Ointment Pharma / BioTech / Nutrition 2026/03/02 More Ono Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory Pharma / BioTech / Nutrition 2026/02/16 More SCHOTT Pharma Launches EVERIC® Lyo & Amber Vials for Light-sensitive ADCs Pharma / BioTech / Nutrition 2026/01/22 More Arbitration Tribunal Upholds Ipsen’s Termination of R&D Agreement with Galderma Pharma / BioTech / Nutrition 2026/01/21 More New Data Reinforces Ipsen’s Commitment to Bringing Solutions and Addressing Care Gaps in Neurological Diseases At TOXINS Pharma / BioTech / Nutrition 2026/01/15 More Opdivo® Intravenous Infusion Approved in Taiwan in Combination with Yervoy® for the Treatment of Adult Patients Pharma / BioTech / Nutrition 2026/01/14 More

---

Page: « Previous 1 2 3 4 5 6 7 8 9 10 ... Next »